Given that RBM15 depletion reduces fumarate levels, which could potentially enhance CD8+ T cell activation and increase anti-tumor immune responses, we next determine whether RBM15 deficiency could inhibit tumorigenesis via enhanced immune surveillance. Here, CD8A is linked to neoplasm.